Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03163641 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of OBG vs.a Bandage Contact Lens for Large Corneal Epithelial Defects in Patients Post-PRK.
A NA study, sponsored by Eyegate Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03163641 is a NA study that has completed, run by Eyegate Pharmaceuticals. The registered enrollment target is 45 participants.
The verdict
NCT03163641, a NA study, has completed, sponsored by Eyegate Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This is a prospective, randomized (Reading Center), masked, controlled study in up to 45 subjects who have undergone bilateral PRK with epithelial removal using alcohol in a 9.0 mm well or trephine at the time of surgery to ensure consistency of the size of the ablation area.
Interventions
- DEVICE Acuvue Oasys
- DEVICE Ocular Bandage Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2018-08-05 |
| Est. Completion | 2018-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03163641
The ClinicalTrials.gov registry entry for NCT03163641 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eyegate Pharmaceuticals, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acuvue Oasys is the first listed.
NCT03163641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03163641 about?
NCT03163641 is a clinical study titled "Safety and Effectiveness of OBG vs.a Bandage Contact Lens for Large Corneal Epithelial Defects in Patients Post-PRK.". This is a prospective, randomized (Reading Center), masked, controlled study in up to 45 subjects who have undergone bilateral PRK with epithelial removal using alcohol in a 9.0 mm well or trephine at the time of surgery to ensure consistency of the size of the ablation area.
What is the current status of trial NCT03163641?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2018-08-05. Estimated completion is 2018-11-08.
What interventions are being tested in trial NCT03163641?
The interventions under investigation include: Acuvue Oasys (DEVICE), Ocular Bandage Gel (DEVICE).
Who is sponsoring clinical trial NCT03163641?
This trial is sponsored by Eyegate Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.